Showing 1-10 of 1100 results for "".
The State of Dermatology Entrepreneurship 2015
https://practicaldermatology.com/topics/practice-management/the-state-of-dermatology-entrepreneurship-2015/18913/William Ju, MD, President of Advancing Innovation in Dermatology talks about entrepreneurship in dermatology. Where are new ideas, technologies, and therapies coming from, and how will they move ahead? Dr. Ju talks about the role of the pharmaceutical industry and finding resources.Innovation in Dermatology Entrepreneurship
https://practicaldermatology.com/topics/practice-management/innovation-in-dermatology-entrepreneurship/18912/Entrepreneurship in dermatology is "in a good spot," says William Ju, MD, President of Advancing Innovation in Dermatology. Dermatology is a high-growth field, supported by patient demand and globalization and scientific advancements.- LEO Pharma and Advancing Innovation in Dermatology Partner to Help Finance Accelerator Fundhttps://practicaldermatology.com/news/leo-pharma-and-advancing-innovation-in-dermatology-partner-to-help-finance-accelerator-fund/2457713/LEO Pharma and its Boston-based R&D innovation unit LEO Science & Tech Hub, and Advancing Innovation in Dermatology (AID) will each contribute $500,000 into the recently created Advancing Innovation in Dermatology Accelerator Fund. This non-profit fund is unique in its approach for supporting produ…
- Call for Entries: Hacking Dermatology 2020 Innovation Challenge to Focus on Dermatologic Challenges in Skin of Colorhttps://practicaldermatology.com/news/call-for-entries-hacking-dermatology-2020-innovation-challenge-to-focus-on-dermatologic-challenges-in-skin-of-color/2460562/Applications are now being accepted for Hacking Dermatology 2020, a dermatology innovation challenge that unites clinical and scientific experts, patients, engineers and innovators to reimagine the landscape of patient care. Now in its third year, Hacking Dermatology is a partnership between Adva…
Allergan Board Rejects Latest Valeant Bid; Topical Jublia Approved for Onychomycosis
https://practicaldermatology.com/series/dermwire-tv/dwtv-6-12/19122/Allergan's board rejects the latest merger proposal from Valeant and the FDA approves topical Jublia for onychomycosis. LEarn about these developments and hear from the AMA's new president in this edition of DermWireTV.Julie Harper, MD, Reacts to New Report on Acne Products with Benzoyl Peroxide (BPO)
https://practicaldermatology.com/topics/acne-rosacea/julie-harper-md-reacts-new-report-acne-products-benzoyl-peroxide-bpo/24172/In this video, Julie Harper, MD, a dermatologist with the Dermatology and Skin Care Center of Birmingham, AL, provides her thoughts on the recent Valisure report showing that some common acne products with benzoyl peroxide (BPO) may contain benzene. She says she’s been an “avid prescriber” of acne pDERM2020 Content Recap: Julie Harper, MD
https://practicaldermatology.com/conferences/dermatology-education-foundation-derm-2020/derm2020-content-recap-julie-harper-md/19844/DERM20920 Faculty Julie Harper, MD discusses what’s new in rosacea from her presentation during DERM2020.Juvederm Approved for Lips, CoolMini Applicator Cleared
https://practicaldermatology.com/topics/psoriasis/juvederm-approved-for-lips-coolmini-applicator-cleared/18828/In this edition, a look at Allergan's Juvederm Voluma XC approval for lips an Zeltiq's CoolMini applicator for treatment of the sub mental area. Plus, there's new data for secukinumab in psoriatic arthritis (PSA) and Kathleen Sebelius has joined the Board of Directors of Dermira.Julie Woodward: "If I could…"
https://practicaldermatology.com/topics/practice-management/julie-woodward-if-i-could-/19052/A well known oculoplastic surgeon, Julie Woodward, MD explains what device would complement the laser and energy-based device systems she already has in her busy practice. See which device she's pick.Julius Few: "If I could…"
https://practicaldermatology.com/topics/practice-management/julius-few-if-i-could-/19086/If he could buy any one laser or energy based device for his practice, Julius Few, MD says he would invest in another device he already owns! Learn what he had to say and what his experience has been.
- Prev
- Next